Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current challenges in Wilms' tumor management.

Lyndon M Gommersall1, Manit Arya, Imran Mushtaq

  • 1Great Ormond Street Hospital, London, UK.

Nature Clinical Practice. Oncology
|November 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A standardised risk-stratified approach to the urological management of children with spina bifida.

Journal of pediatric urology·2026
Same author

Intraoperative ultrasound in nephron-sparing surgery for paediatric renal tumours: A single-centre cohort study.

Journal of pediatric surgery·2026
Same author

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

JAMA oncology·2026
Same author

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines.

Molecular oncology·2025
Same author

The Fracture Ankle Implant Review (FAIR) study : a national multicentre retrospective review of practice in implant choice, fixation methods, and outcomes in fixation of the fibula in ankle fractures.

Bone & joint open·2025
Same author

Use of a Template-Matching Clavicle Fracture Atlas for Surrogate Dating of Humeral and Femoral Fractures in Young Infants: A Six-Reader Study.

AJR. American journal of roentgenology·2025
Same journal

Targeting EGFR in head and neck cancer: a decade of progress.

Nature clinical practice. Oncology·2009
Same journal

Re: The clinical trials system is broken.

Nature clinical practice. Oncology·2009
Same journal

Re: Precancerous lesions of the breast.

Nature clinical practice. Oncology·2009
Same journal

Effect of bisphosphonates on pain and quality of life in patients with bone metastases.

Nature clinical practice. Oncology·2009
Same journal

Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors.

Nature clinical practice. Oncology·2009
Same journal

Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck.

Nature clinical practice. Oncology·2009
See all related articles

Wilms tumor, a childhood kidney cancer, now has an 85% survival rate due to successful clinical trials. Treatment is optimized by stratifying patients based on tumor stage and histology, reducing morbidity.

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Cancer Research

Background:

  • Wilms tumor is a common pediatric renal cancer affecting children under two.
  • Recent clinical trials have improved survival rates to 85% and reduced treatment-related morbidity.
  • Less-intensive chemotherapy regimens are now available for patients with favorable prognostic factors.

Purpose of the Study:

  • To discuss current management strategies for Wilms tumor.
  • To highlight advances in treating this childhood kidney cancer.
  • To explore the role of prognostic factors in optimizing treatment.

Main Methods:

  • Review of established and salvage chemotherapy regimens.
  • Discussion of treatment stratification based on tumor stage and histology.

Related Experiment Videos

  • Analysis of treatment-related morbidity and survival outcomes.

    • Main Results:

    • Overall survival for Wilms tumor patients has reached 85%.
    • Treatment-related morbidity has been significantly reduced.
    • Stratification by stage and histology allows for optimized, less-aggressive chemotherapy.

    Conclusions:

    • Wilms tumor management has advanced significantly, improving survival and reducing morbidity.
    • Patient stratification based on prognostic factors is key to optimizing treatment.
    • Further research is needed to refine current regimens and identify new prognostic factors.